News
04-25-2011, 08:01 AM
The Government of Rwanda, together with QIAGEN N.V. and Merck, known as MSD outside the United States and Canada, today announced the launch, in Kigali, Rwanda, of a comprehensive national cervical cancer prevention program that includes vaccination with GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for appropriate girls 12 to 15 years of age and modern molecular diagnostic screening for women between the ages of 35 and 45.
More... (http://www.news-medical.net/news/20110425/Rwanda-QIAGEN-and-Merck-launch-comprehensive-national-cervical-cancer-prevention-program.aspx)
More... (http://www.news-medical.net/news/20110425/Rwanda-QIAGEN-and-Merck-launch-comprehensive-national-cervical-cancer-prevention-program.aspx)